These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 37867428)
41. Clinical Characteristics and Risk Factors for Mortality in Critical COVID-19 Patients Aged 50 Years or Younger During Omicron Wave in Korea: Comparison With Patients Older Than 50 Years of Age. Shi HJ; Yang J; Eom JS; Ko JH; Peck KR; Kim UJ; Jung SI; Kim S; Seok H; Hyun M; Kim HA; Kim B; Joo EJ; Cheong HS; Jun CH; Wi YM; Kim J; Kym S; Lim S; Park Y J Korean Med Sci; 2023 Jul; 38(28):e217. PubMed ID: 37463688 [TBL] [Abstract][Full Text] [Related]
42. Risks of catching COVID-19 according to vaccination status of healthcare workers during the SARS-CoV-2 Delta variant dominant period and their clinical characteristics. Özüdoğru O; Acer Ö; Genç Bahçe Y J Med Virol; 2022 Aug; 94(8):3706-3713. PubMed ID: 35419851 [TBL] [Abstract][Full Text] [Related]
43. The modified NUTRIC score can be used for nutritional risk assessment as well as prognosis prediction in critically ill COVID-19 patients. Zhang P; He Z; Yu G; Peng D; Feng Y; Ling J; Wang Y; Li S; Bian Y Clin Nutr; 2021 Feb; 40(2):534-541. PubMed ID: 32527576 [TBL] [Abstract][Full Text] [Related]
44. Association Between Vaccination Status and Mortality Among Intubated Patients With COVID-19-Related Acute Respiratory Distress Syndrome. Grapsa E; Adamos G; Andrianopoulos I; Tsolaki V; Giannakoulis VG; Karavidas N; Giannopoulou V; Sarri K; Mizi E; Gavrielatou E; Papathanakos G; Mantzarlis KD; Mastora Z; Magira E; Koulouras V; Kotanidou A; Siempos II JAMA Netw Open; 2022 Oct; 5(10):e2235219. PubMed ID: 36205996 [TBL] [Abstract][Full Text] [Related]
45. Comparison of the Clinical and Laboratory Findings and Outcomes of Hospitalized COVID-19 Patients Who Were Either Fully Vaccinated with Coronavac or Not: An Analytical, Cross Sectional Study. Yavuz SŞ; Tunçer G; Altuntaş-Aydın Ö; Aydın M; Pehlivanoğlu F; Tok Y; Mese S; Gündüz A; Güçlü CG; Özdoğan İ; Hemiş-Aydın B; Soğuksu P; Benli A; Başaran S; Midilli K; Eraksoy H Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632489 [TBL] [Abstract][Full Text] [Related]
46. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study. Xiong X; Lui DTW; Chung MSH; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Cheng FWT; Cheung CL; Chan EWY; Lee CH; Woo YC; Tan KCB; Wong CKH; Wong ICK PLoS Med; 2023 Jul; 20(7):e1004274. PubMed ID: 37486927 [TBL] [Abstract][Full Text] [Related]
47. Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong. Li X; Gao L; Tong X; Chan VKY; Chui CSL; Lai FTT; Wong CKH; Wan EYF; Chan EWY; Lau KK; Lau CS; Wong ICK J Autoimmun; 2022 Jun; 130():102830. PubMed ID: 35461018 [TBL] [Abstract][Full Text] [Related]
48. COVID-19 vaccination during pregnancy: coverage and safety. Blakeway H; Prasad S; Kalafat E; Heath PT; Ladhani SN; Le Doare K; Magee LA; O'Brien P; Rezvani A; von Dadelszen P; Khalil A Am J Obstet Gynecol; 2022 Feb; 226(2):236.e1-236.e14. PubMed ID: 34389291 [TBL] [Abstract][Full Text] [Related]
49. CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study. Paixao ES; Wong KLM; Alves FJO; de Araújo Oliveira V; Cerqueira-Silva T; Júnior JB; Machado TM; Junior EPP; Boaventura VS; Penna GO; Werneck GL; Rodrigues LC; Pearce N; Barreto ML; Barral-Netto M BMC Med; 2022 Apr; 20(1):146. PubMed ID: 35379250 [TBL] [Abstract][Full Text] [Related]
50. Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study. Mok CKP; Chen C; Zhao S; Sun Y; Yiu K; Chan TO; Lai HL; Lai KC; Lau KM; Ling KC; Chan KKP; Ng SS; Ko FW; Peiris M; Hui DS Lancet Microbe; 2023 Jun; 4(6):e418-e430. PubMed ID: 37086735 [TBL] [Abstract][Full Text] [Related]
51. Antibody responses to COVID-19 vaccines in older adults. Bag Soytas R; Cengiz M; Islamoglu MS; Borku Uysal B; Yavuzer S; Yavuzer H J Med Virol; 2022 Apr; 94(4):1650-1654. PubMed ID: 34921432 [TBL] [Abstract][Full Text] [Related]
52. The Actual Status of Hospitals as COVID-19 Vaccination Clinics in China and Safety Monitoring of Inactivated Vaccine: A Cross-Sectional Study. Huang J; Zhang MQ; Huang MZ; Lin GM Disaster Med Public Health Prep; 2022 Aug; 17():e256. PubMed ID: 36017705 [TBL] [Abstract][Full Text] [Related]
53. Vaccination status and outcomes in critical COVID-19 patients. Costa PN; Pereira JO; Cañigral AH; Quintana EM; Sanchez-Nieto JM; Delis PB; Villarroya AR; Gomez LL; Fernandez NA; Alcaraz AC J Bras Pneumol; 2024; 50(1):e20230116. PubMed ID: 38422336 [TBL] [Abstract][Full Text] [Related]
54. Demographics and Clinical Characteristics of COVID-19-vaccinated Patients Admitted to ICU: A Multicenter Cohort Study from India (PostCoVac Study-COVID Group). Havaldar AA; Prakash J; Kumar S; Sheshala K; Chennabasappa A; Thomas RR; Sushmitha EC; Khan MS; Kumar R; Kindo S; Singh R; Kartik M; Swamy AHM; Raj JM; Thomas T; Selvam S Indian J Crit Care Med; 2022 Nov; 26(11):1184-1191. PubMed ID: 36873595 [TBL] [Abstract][Full Text] [Related]
55. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers. Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048 [TBL] [Abstract][Full Text] [Related]
56. Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19. Dogan M; Yilmaz B Acta Pharm; 2023 Jun; 73(2):257-268. PubMed ID: 37307370 [TBL] [Abstract][Full Text] [Related]
57. Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients. Wong CKH; Lui DTW; Xiong X; Chui CSL; Lai FTT; Li X; Wan EYF; Cheung CL; Lee CH; Woo YC; Au ICH; Chung MSH; Cheng FWT; Tan KCB; Wong ICK BMC Med; 2022 Oct; 20(1):339. PubMed ID: 36229814 [TBL] [Abstract][Full Text] [Related]
58. Epidemiology, outcomes, and utilization of intensive care unit resources for critically ill COVID-19 patients in Libya: A prospective multi-center cohort study. Elhadi M; Alsoufi A; Abusalama A; Alkaseek A; Abdeewi S; Yahya M; Mohammed A; Abdelkabir M; Huwaysh M; Amkhatirah E; Alshorbaji K; Khel S; Gamra M; Alhadi A; Abubaker T; Anaiba M; Elmugassabi M; Binnawara M; Khaled A; Zaid A; Msherghi A PLoS One; 2021; 16(4):e0251085. PubMed ID: 33930079 [TBL] [Abstract][Full Text] [Related]
59. Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin ®) in healthcare workers in Mumbai, India: A retrospective cohort analysis. Contractor A; Shivaprakash S; Tiwari A; Setia MS; Gianchandani T PLoS One; 2022; 17(10):e0276759. PubMed ID: 36301977 [TBL] [Abstract][Full Text] [Related]
60. Adverse outcomes of SARS-CoV-2 infection with delta and omicron variants in vaccinated versus unvaccinated US veterans: retrospective cohort study. Bohnert AS; Kumbier K; Rowneki M; Gupta A; Bajema K; Hynes DM; Viglianti E; O'Hare AM; Osborne T; Boyko EJ; Young-Xu Y; Iwashyna TJ; Maciejewski M; Schildhouse R; Dimcheff D; Ioannou GN BMJ; 2023 May; 381():e074521. PubMed ID: 37220941 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]